Portal de Periódicos da CAPES

Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study

2022; RELX Group (Netherlands); Linguagem: Inglês

10.2139/ssrn.4070408

1556-5068

Rafaella Fortini Queiroz Grenfell, Nathalie Bonatti Franco Almeida, Priscilla Soares Filgueiras, Camila Amormino Corsini, Sarah Gomes, Daniel AP de Miranda, Adelina J. Lourenço, Olindo Assis Martins Filho, Jaquelline Germano de Oliveira, Andréa Teixeira‐Carvalho, Guilherme RF Campos, Maurício Lacerda Nogueira, Pedro Augusto Alves, Gabriel da Rocha Fernandes, Leda R. Castilho, Túlio M. Lima, Daniel PB de Abreu, Renata G. F. Alvim, Thaís Bárbara de S. Silva, Wander de Jesus Jeremias, Dayane Andriotti Otta, Ana Caroline Campi-Azevedo,

COVID-19 Clinical Research Studies

Download This Paper Open PDF in Browser Add Paper to My Library Share: Permalink Using these links will ensure access to this page indefinitely Copy URL Copy DOI